APA (7th ed.) Citation

L, P., A, Z., A, B., C, J., KE, H., F, W., . . . CK, S. (2026). Biomarker-Based Prediction of OATP1B1 Activity in Clinical Routine-Investigating Coproporphyrins as Markers for Drug-Drug-Gene Interactions. Clinical pharmacology and therapeutics, 120(2), 492. https://doi.org/10.1002/cpt.70335

Chicago Style (17th ed.) Citation

L, Potzel, et al. "Biomarker-Based Prediction of OATP1B1 Activity in Clinical Routine-Investigating Coproporphyrins as Markers for Drug-Drug-Gene Interactions." Clinical Pharmacology and Therapeutics 120, no. 2 (2026): 492. https://doi.org/10.1002/cpt.70335.

MLA (9th ed.) Citation

L, Potzel, et al. "Biomarker-Based Prediction of OATP1B1 Activity in Clinical Routine-Investigating Coproporphyrins as Markers for Drug-Drug-Gene Interactions." Clinical Pharmacology and Therapeutics, vol. 120, no. 2, 2026, p. 492, https://doi.org/10.1002/cpt.70335.